C1GALT1C1 and hepatocellular carcinoma: Subsequently, Shen developed a new clinical prediction model for hepatocellular carcinoma based on risk factors identified in multiple regression, such as Cosmc expression, vascular invasion, and TNM stage, and validated it using an external cohort from the TCGA database, which showed that Cosmc expression can improve the ability to predict HCC prognosis [135].